Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recro Pharma announced its CDMO division, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.
read more
Haemonetics and CSL Plasma have announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma.
read more
Wednesday, March 31, 2021
Ajinomoto and Bright Peak Therapeutics announced a research collaboration and exclusive license agreement to incorporate AJICAP, Ajinomoto’s proprietary site-specific bioconjugation technology.
read more
Lonza announced today the construction of a new small molecule manufacturing complex at its Visp (CH) site.
read more
Harbour BioMed and PPD announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
read more
RenovaCare has expanded its engagement with MCRA to continue to advance the Company’s FDA program.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more
MilliporeSigma has announced the expansion of its state-of-the-art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor. With the new upstream suite at its Biodevelopment Center in...
read more
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, has announced the final results of the VERKKO remote online Phase IV clinical trial for diabetes.
read more
Woodstock Sterile Solutions has named Oliver Vogt as its Vice President and General Manager – Site Operations.
read more
Friday, February 16, 2024
Catalyst Clinical Research announced that Nik Morton, the company's president and COO, assumed its CEO role on 12 February 2024. Mr. Morton joined Catalyst as its COO in 2022. Mr. Morton moved into his new position while Nick Dyer, Catalyst's former ...
read more
Tuesday, October 21, 2025
Ajinomoto Bio-Pharma Services and Gene Tools have announced a collaboration to expand access to phosphorodiamidate morpholino oligomer (PMO) therapeutics, a growing class of oligonucleotide drugs that show promise in treating genetic diseases such as...
read more
The FDA posted warning letters to four companies who produce homeopathic drug products for significant violations of CGMP.
read more
Thursday, September 17, 2015
A newly released study has found that risk-sharing agreements (RSAs) between pharmaceutical companies and health insurers—which could significantly transform the cost and accessibility of medications—are not widely utilized in the U.S. today, but ...
read more
ICON announced that it has acquired the Mapi Group.
read more